Gennex Laboratories (BOM:531739) Total Receivables: ₹436 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531739 Gennex Laboratories Ltd BOM:531739
77 GF Score
Price ₹8.86
GF Value ₹15.57
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Gennex Laboratories Total Receivables?

Gennex Laboratories BOM:531739 +0.91% 77 Total Receivables is ₹436 Mil as of Mar. 2026. GuruFocus rates BOM:531739 with a GF Score™ of 77/100 and a GF Value™ of ₹15.57 (Possible Value Trap). The stock has 7 warning signs investors should review.

Gennex Laboratories's Total Receivables for the quarter that ended in Mar. 2026 was ₹436 Mil.

Gennex Laboratories Total Receivables Related Terms

Gennex Laboratories Total Receivables Historical Data

* Premium members only.

The historical data trend for Gennex Laboratories's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gennex Laboratories Total Receivables Chart

Gennex Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 299.52 148.76 319.46 455.40 435.57

Gennex Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 455.40 0.00 1,752.16 0.00 435.57
BOM:531739
77GF Score
Gennex Laboratories Ltd BOM:531739
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gennex Laboratories Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₹436 Mil mean?
Gennex Laboratories (BOM:531739) has a Total Receivables of ₹436 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Gennex Laboratories and its competitors.
Is Gennex Laboratories' Total Receivables too high?
Gennex Laboratories' current Total Receivables is ₹436 Mil. Overall, Gennex Laboratories has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gennex Laboratories' Total Receivables compare to ZTS?
Gennex Laboratories' Total Receivables of ₹436 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Gennex Laboratories and its competitors. Gennex Laboratories's current Total Receivables is ₹436 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gennex Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Gennex Laboratories (BOM:531739) is currently considered Possible Value Trap. The stock's GF Value™ is ₹15.57, compared to a current price of ₹8.86 — trading 43.1% below its estimated fair value. The current Total Receivables is ₹436 Mil. Gennex Laboratories' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Gennex Laboratories (BOM:531739), the current Total Receivables is ₹436 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gennex Laboratories (BOM:531739) Overvalued in 2026?

Based on GuruFocus' analysis, Gennex Laboratories stock appears to be undervalued. The current stock price of ₹8.86 is trading 43.1% below its estimated GF Value™ of ₹15.57. GuruFocus considers Gennex Laboratories to be Possible Value Trap.

Key valuation signals for BOM:531739:

  • Total Receivables: ₹436 Mil
  • GF Value™: ₹15.57 vs. price of ₹8.86 (43.1% below fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the BOM:531739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gennex Laboratories Business Description

Address Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.
77GF Score

Get the complete analysis for BOM:531739

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8.86
Price
₹15.57
GF Value